Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Plasmati

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Brain : a Journal of Neurology|July 9, 2004
Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR studyL Guerrini, F Lolli, A Ginestroni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 22, 2012
Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-PainL Padua, C Briani, A Truini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Brain : a Journal of Neurology|July 9, 2004
Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR studyL Guerrini, F Lolli, A Ginestroni, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 22, 2012
Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-PainL Padua, C Briani, A Truini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
Pageof 4